Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · IEX Real-Time Price · USD
1.095
-0.005 (-0.45%)
Jul 22, 2024, 10:07 AM EDT - Market open
Ocean Biomedical Employees
Ocean Biomedical had 9 employees as of December 31, 2021. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$10,954,778
Market Cap
37.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 9 | 1 | 12.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
Precision Optics Corporation | 85 |
electroCore | 68 |
Aligos Therapeutics | 66 |
Cue Biopharma | 53 |
Curis | 49 |
IN8bio | 31 |
Acurx Pharmaceuticals | 4 |
OCEA News
- 6 weeks ago - Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 - GlobeNewsWire
- 7 weeks ago - Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewsWire
- 2 months ago - Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease - GlobeNewsWire
- 3 months ago - Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K - GlobeNewsWire
- 4 months ago - Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL - GlobeNewsWire
- 5 months ago - Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting - GlobeNewsWire
- 8 months ago - Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody - GlobeNewsWire
- 8 months ago - Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics - GlobeNewsWire